`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`M AN l t-3 1.Z LJ MA 8
`Business Use Only
`
`Meeting Date: Aug 6, 2012
`Meeting Notes Date: Aug 12, 2012
`Author:
`Room: WSJ-340.3.09
`
`Dial-in: ..w..
`
`Teleoonferences.msg
`
`Team Members : (✓ = Present, *= part-time)
`
`Team Mem bers:(✓ = Present,*= part-time)
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`1 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Topic/Situation: Project update
`
`OiSCU$SiO0
`
`Achievements
`
`Issues
`What
`
`Actions
`What
`
`Topic/Situation
`
`o en
`
`Who
`
`Closed
`
`WheP
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`2 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Achievements
`
`I
`I
`I
`
`Issues
`What
`
`Actions
`
`Topic/Situation
`
`Discussion
`
`Achievements
`
`Issues
`What
`
`o en
`
`Who
`
`-
`
`Closed
`
`When
`
`Lead:
`
`Pre-reads
`
`none
`
`o en
`
`Closed
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`3 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMAT ION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.003
`Regeneron v. Novartis, IPR2021 -00816
`
`
`
`Actions
`
`When
`
`Topic/Situation
`
`Pre-reads
`
`Issues
`What
`
`Actions
`What
`
`Topic/Situation
`
`Discussion
`
`Achievements
`
`Issues
`What
`
`Oen
`
`Closed
`
`Who
`
`■
`
`When
`
`Lead:
`
`Pre-reads
`
`none
`
`o en
`
`Closed
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`4 of 7
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Who -
`
`O n
`
`Closed
`
`Actions
`
`Topic/Situation
`
`Achievements
`
`Topic/Situation
`
`Achievements
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`5 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Issues
`What
`
`Actions
`What
`
`Closed
`
`When
`
`Oen
`
`Who
`
`-
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`6 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Consolidated Action Plan
`
`What
`
`-
`
`Who
`
`When
`
`-
`----
`
`Activity description
`
`Code
`
`LF
`
`TRD Subteam Meeting Minutes: Date of Meeting: August 6, 2012
`
`7 of 7
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2082.007
`Regeneron v. Novartis, IPR2021-00816
`
`